Edward J Dulac III
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $234K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 24SEC | NTLAIntellia Therapeutics, Inc. | Sell | 8,111148,175 held (−5%) | $11.25 | $91K | +1.5% |
| Jul 6SEC | NTLAIntellia Therapeutics, Inc. | Sell Plan | 4,677156,286 held (−3%) | $18.00 | $84K | -36.6% |
| Jan 7SEC | NTLAIntellia Therapeutics, Inc. | Sell | 6,37999,683 held (−6%) | $9.21 | $59K | +24.0% |
- Sell
CFO Edward J Dulac III sold $84K of NTLA at $18.00 — pre-scheduled 10b5-1 plan sale.